Agilent Technologies (A) has completed the acquisition of Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners, the company said Thursday.
The company said Biocare Medical will be integrated into its Life Sciences and Diagnostics Markets Group, strengthening its pathology portfolio across clinical and research settings.
Agilent said the deal is expected to be accretive to its top-line growth rate, margin profile and non-instrument revenue mix in the first year, with earnings per share accretion anticipated approximately 12 months after closing.